A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.
Also called NCT06539689
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 240 participants
- Sponsor
- FrontAce Scientific Co., Ltd
- Registry
-
NCT06539689
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06539689. Randomized; no masking; primary purpose treatment. Start 2024-06-04 (actual); primary completion 2026-12-04 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries
- Acronym
- SURF
- Condition
- Peripheral Arterial Disease
- Condition
- Stenosis
- Condition
- Dissection
- Intervention (Device)
- Sperstent® peripheral spot stent system
- Intervention (Device)
- Everflex® self-expanding peripheral stent system
- Lead sponsor
- FrontAce Scientific Co., Ltd
Record details
- Record id
cardio:ct-nct06539689- Content hash
988fac28e480cfb5d5542a9bbe346afda77b01776eca1f79facca7664adf8889